← Back to headlines
Mayne Pharma Reports Higher Margins in Second Half of Fiscal 2026
Pharmaceutical company Mayne Pharma announced improved profit margins during the second half of fiscal 2026, highlighting operational efficiencies and strong product performance.
27 Aug, 00:23 — 27 Aug, 00:23
Sources
Showing 1 of 1 sources
Related Stories
Energy Sector Firms Report Strong Financial Performance for Early 2026
21m ago
Qantas Reports Lowest Profits in Four Years Amid Soaring Jet Fuel Costs
24m ago
Accenture to Acquire Japanese Software Firm COMWARE to Expand Mid-Market Reach
27m ago
France Eases Cheese Production Rules Amid Severe Agricultural Drought
36m ago